The next generation?
Second-generation biologics are now entering the marketplace.
D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D001709:Biotechnology / Q000191:economics / Q000639:trends; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D004921:Erythropoietin / Q000191:economics*; D008389:Marketing of Health Services; D011993:Recombinant Fusion Proteins / Q000191:economics*; D011994:Recombinant Proteins
D000911:Antibodies, Monoclonal; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D004921:Erythropoietin